Template:Map/Ether phospholipid: Difference between revisions
No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
|style="text-align:center;"|1-acyl dihydroxy acetone p | |style="text-align:center;"|1-acyl dihydroxy acetone p | ||
|{{Map/ReactionLeftRight|NADH|NAD+|[http://metabolomics.jp/wiki/Enzyme:1.1.1.8 1.1.1.8]}} | |{{Map/ReactionLeftRight|NADH|NAD+|[http://metabolomics.jp/wiki/Enzyme:1.1.1.8 1.1.1.8]}} | ||
|style="text-align:center;"|1-acyl ''sn''-glycerol 3p>[[Image:1CSG3P.png]] | |style="text-align:center;"|1-acyl ''sn''-glycerol 3p<br/>[[Image:1CSG3P.png]] | ||
|- | |- | ||
|{{Map/ReactionDown35inout|R1-OH|<small>→R-COOH</small>|}}1-alkyl dihydroxy acetone p<ref>アルキル型を含むエーテルリン脂質はペルオキシソームで合成。ペルオキシソームを欠乏するZellweger症候群では血小板活性化因子PAFが著しく減少。</ref>{{Map/ReactionDown35inout|NADPH|<small>→NADP+</small>|}} | |{{Map/ReactionDown35inout|R1-OH|<small>→R-COOH</small>|}}1-alkyl dihydroxy acetone p<ref>アルキル型を含むエーテルリン脂質はペルオキシソームで合成。ペルオキシソームを欠乏するZellweger症候群では血小板活性化因子PAFが著しく減少。</ref>{{Map/ReactionDown35inout|NADPH|<small>→NADP+</small>|}} | ||
Revision as of 06:51, 3 July 2009
Ether Phospholipid Biosynthesis
エーテルリン脂質の生合成
dihydroxy acetone p
|
1.1.1.8 NADH NAD+ |
sn-glycerol 3p
| ||||||||||
| 1-acyl dihydroxy acetone p | 1.1.1.8 NADH NAD+ |
1-acyl sn-glycerol 3p File:1CSG3P.png | ||||||||||
|
| |||||||||||
| 1-alkyl sn-glycerol 3p File:1KSG3P.png
|
1-acyl sn-glycerol 3p or lyso-phosphatidate >
| |||||||||||
| 1-alkyl 2-acyl sn-glycerol 3p File:1K2CSG3P.png
|
1,2-diacyl sn-glycerol 3p or phosphatidate 
| |||||||||||
1-alkyl 2-acyl sn-glycerol
platelet-activating factor (PAF; 2=acetyl) |
1,2-diacyl and triacyl sn-glycerol |
